A decreasing trend with advancing age was also observed in the frequency of solicited adverse events.
← all excerpts
Long-term immunogenicity of an AS03-adjuvanted influenza A(H1N1)pdm09 vaccine in young and elderly adults: an observer-blind, randomized trial.
1
—
—